• Western blot analysis of extracts of various cell lines, using ARHGAP25 antibody (STJ115620) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 30s.

Anti-ARHGAP25 antibody (1-370) (STJ115620)

SKU:
STJ115620

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-ARHGAP25 (1-370) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ARHGAP25
Gene ID: 9938
Uniprot ID: RHG25_HUMAN
Immunogen Region: 1-370
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-370 of human ARHGAP25 (NP_001159748.1).
Immunogen Sequence: MSLGQSACLFLSIARSRSVM TGEQMAAFHPSSTPNPLERP IKMGWLKKQRSIVKNWQQRY FVLRAQQLYYYKDEEDTKPQ GCMYLPGCTIKEIATNPEEA GKFVFEIIPASWDQNRMGQD SYVLMASSQAEMEEWVKFLR RVAGTPCGAVFGQRLDETVA YEQKFGPHLVPILVEKCAEF ILEHGRNEEGIFRLPGQDNL VKQLRDAFDAGERPSFDRDT DVHTVASLLKLYLRDLPEP
Function GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.
Protein Name Rho Gtpase-Activating Protein 25
Rho-Type Gtpase-Activating Protein 25
Database Links Reactome: R-HSA-9013149
Alternative Antibody Names Anti-Rho Gtpase-Activating Protein 25 antibody
Anti-Rho-Type Gtpase-Activating Protein 25 antibody
Anti-ARHGAP25 antibody
Anti-KIAA0053 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance